A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells

Author(s):
Lameijer, L.N.; Ernst, D.; Hopkins, S.L.; Meijer, M.S. (0000-0003-0877-2374); Askes, S.H.C.; Le Dévédec, S.E. (0000-0002-0615-9616); Bonnet, S.A. (0000-0002-5810-3657)
Published
2017
Publication type
Article / Letter to editor
anti-tumor agentshypoxiaphotopharmacologyred-light activationruthenium
Date issued
2017-09-11
Language
English
Is part of
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017), Vol. 56, no. 38, p. 11549-11553
hdl
1887/59300
doi
10.1002/anie.201703890